In-vitro evaluation of the pharmacological and therapeutic equivalence of some acetaminophen trademarks


  • Juan Castellar-Buelvas Facultad de Medicina, Universidad de Cartagena, Cartagena de Indias, Colombia
  • Marlene Duran-Lengua Facultad de Medicina, Universidad de Cartagena, Cartagena de Indias, Colombia
  • Alexander Troncoso-Palacio Dpto. Productividad e Innovación, Universidad de la Costa, Barranquilla, Colombia



Comparison of Acetaminophen and Tylenol, In Vitro Experiments, Pharmaceutical and Therapeutic Equivalence, Quality in Drugs


There are currently many laboratories throughout the world that sell acetaminophen with legal registration. However, the fact that it is a legal drug does not ensure its quality, as it may undergo changes during its manufacture or marketing, which can affect its efficacy and pharmaceutical safety. Therefore, this project was developed, in which 30% of the brands of acetaminophen 500 mg tablets marketed in Colombia were analysed with the aim of determining their pharmacological and therapeutic equivalence. Know the pharmaceutical characteristics and therapeutic similarity between the different brands of acetaminophen analysed a methodology was followed in accordance with the parameters and guidelines of the United States Pharmacopeia 42, National Form 37, and Resolution 1124 of the Ministry of Health and Social Protection of the Colombian government. The samples' dissolving profiles at different pH values were then compared, and tests were run to check for impurities, content, uniformity, and dissolution. The results of these analyses are all totally consistent with the pharmacological and therapeutic equivalents. These comply both with the physical-chemical quality control parameters required as well as with therapeutic equivalence. From the findings of this investigation, it was concluded that since there is no evidence of significant differences between the brands analysed, it is recommended that those who need to buy acetaminophen or Tylenol from the brands surveyed can purchase any of them with complete confidence that any of them will have the same pharmaceutical quality and the same therapeutic performance.


Download data is not yet available.


Acetaminofén, el medicamento más prescrito en colombia en 2018. (n.d.). Accessed 24 January 2021.

Acetaminophen - ClinicalKey. (n.d.).!/content/ drug_monograph/6-s2.0-4. Accessed 18 August 2021.

Acetaminophen - DrugBank. (n.d.). Accessed 30 September 2020.

Acetaminophen Dosage Guide with Precautions. (n.d.). dosage/acetaminophen.html. Accessed 30 September 2020.

Alertan por posible escasez de acetaminofén en Colombia - Infobae. (n.d.).

/03/16/alertan-por-posible-escasez-de-acetaminofen-en-colombia/. Accessed 30 September 2020.

Anderson, B. J. (2008). Paracetamol (Acetaminophen): Mechanisms of action. Paediatric Anaesthesia, 18(10), 915–921.

Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006). Paracetamol: New Vistas of an Old Drug. CNS Drug Reviews, 12(3-4), 250–275.

Blakely, P., & McDonald, B. R. (1995). Acute renal failure due to acetaminophen ingestion: a case report and review of the literature. Journal of the American Society of Nephrology, 6(1), 48-53.

Castellar-Buelvas, J., & Troncoso-Palacio, A. (2021). Using in vitro cholestyramine as an instead of activated charcoal for the treatment of drug poisoning. International Journal of Research in Engineering and Science, 9(9), 47–54.

Castellar-Buelvas, J., Troncoso-Palacio, A., & Figueroa-Mercado, R. (2022). Acetaminophen Synthesis Reaction Performance Using Ultrasound, Microwave, and Conventional Methods. International Journal of Engineering Inventions, 11(10), 87–94.

Diagrama de Pareto (n.d.). Accessed 26 August 2021.

Dololed: la historia de la caída de un medicamento estrella - Salud - ELTIEMPO.COM. (n.d.). Accessed 24 January 2021.

Ghaffar U.B., & Tadvi, N. A. (2014). Paracetamol Toxicity: A Review. Journal of Contemporary Medicine and Dentistry, 2(3), 12–15.

Graham, G. G., Scott, K. F., & Day, R. O. (2004). Alcohol and paracetamol. Australian Prescriber, 27(1), 14–15.

Inalbon, M., Muñoz, R., & Sallietti, V. (2016). Estudio de bioequivalencia farmacéutica in vitro de comprimidos de Paracetamol 500 mg comercializados en Córdoba, Argentina. Córdoba: Facultad de Ciencias Químicas.

Litalien, C., & Jacqz-Aigrain, E. (2001). Risks and benefits of nonsteroidal anti-inflammatory drugs in children: A comparison with paracetamol. Pediatric Drugs, 3(11), 817–858.

Mancipe, L. C. Fernandez, A. D. C., & Fernandez, A. D. G. (2010). Intoxicación por Acetaminofén. Revista Med, 18(2), 221-227.

Manyike, P. T., Kharasch, E. D., Kalhorn, T. F., & Slattery, J. T. (2000). Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clinical Pharmacology and Therapeutics, 67(3), 275–282.

Paracetamol. (n.d.). Accessed 30 September 2020.

Perry, R. (2010). Perspectives on the bioequivalence and therapeutic equivalence of generic formulations: An overview of the landscape. Clinical Therapeutics, 32(10), 1796–1797.

Prescott, L. F. (2000). Paracetamol, alcohol and the liver. British Journal of Clinical Pharmacology, 49(4), 291–301.

Resolution 1124. (2016). Accessed 20 September 2020.

Sankarraman, S. M. (2022). A computational approach on acetaminophen drug using degree-based topological indices and m-polynomials. Biointerface Research in Applied Chemistry, 12(6), 7249–7266.

Siripruekpong, S., Aphinyankul, J., Chanchayanon, T., Oofuvong, M., Pakpirom, J., Choksuchat, C., Packawatchai, P., & Klongdee, J. N. (2022). Minimal effective dose of ultrasound-guided rectus sheath block to reduce oral analgesic requirement after ambulatory laparoscopic tubal resection: a randomized controlled superiority trial. Trials, 23(1), 228.

Sistema de Tramites en Linea - Consultas Publicas. (n.d.).

consultas/consreg_encabcum.jsp. Accessed 21 January 2021

Tan, E., Hoare, K., Riley, J., Fernando, K., Haskell, L., McKinlay, C. J., Dalziel, S. R., & Braithwaite, I. (2022). Panic or peace – prioritising infant welfare when medicating feverish infants: a grounded theory study of adherence in a paediatric clinical trial. BMC Pediatrics, 22(1), 195.

Tolman, K. G. (1998). Hepatotoxicity of non-narcotic analgesics. American Journal of Medicine, 105(1B), 13S-19S.

Vidhya Malar, H. L., & Mettilda Bai, S. M. (2012). Beware of Paracetamol Toxicity. Journal of Clinical Toxicology, 2(7), 2–4.

Walls, L., Baker, C. F., & Sarkar, S. (2007). Acetaminophen-induced hepatic failure with encephalopathy in a newborn. Journal of Perinatology, 27(2), 133–135.

** (2017). Farmacopea de los Estados Unidos de America Formulario Nacional USP 40 NF 35 (p. 2784). 40th ed. Rockville (EEUU): U. S. Pharmacopeial Convention, Inc.



How to Cite

Castellar-Buelvas, J., Duran-Lengua, M., & Troncoso-Palacio, A. (2024). In-vitro evaluation of the pharmacological and therapeutic equivalence of some acetaminophen trademarks. Journal of Decision Analytics and Intelligent Computing, 4(1), 111–120.